NCT03714776 - A Study to Assess the Safety, Tolerability and Efficacy of IONIS-AGT-LRx, an Antisense Inhibitor Administered Subcutaneously to Hypertensive Participants With Controlled Blood Pressure | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 3, 2019

Primary Completion Date

November 13, 2019

Study Completion Date

November 13, 2019

Conditions

Mild Hypertension

Interventions

DRUG

Placebo

Placebo matching solution administered as SC injection.

DRUG

ISIS 757456

Administered as SC injection.

Trial Locations (6)

York Clinical Research LLC, Norfolk

Progressive Medical Research, Port Orange

Ohio Clinical Research - Lyndhurst, Lyndhurst

Midwest Institute for Clinical Research, Indianapolis

Juno Research, LLC - Northwest Site, Houston

Orange County Research Center, Tustin